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Background
Cardiovascular magnetic resonance (CMR) with delayed
enhancement (DE) has become the gold standard for the
identification and quantification of myocardial fibrosis in
coronary artery disease. In this regard, DE thresholding to
2 standard deviations above normal myocardium is now
considered the most robust method for quantifying fibro-
sis with high accuracy and reproducibility. However,
whether this method is the most appropriate for non-
ischemic cardiomyopathies such as hypertrophic cardio-
myopathy remains uncertain. Our goal was to compare
the performance of various thresholding techniques to a
visual assessment in a large cohort of patients with hyper-
trophic cardiomyopthy (HCM).
Methods
DE-CMR imaging was performed 15 minutes after the
intravenous administration of 0.2 mmol/kg of gadolin-
ium-DTPA (Magnevist, Schering; Berlin, Germany) with a
breath-hold segmented inversion-recovery sequence (TI =
240–300 ms), in 203 HCM patients (42 ± 17 years; 71%
male) from two HCM referral centers. Two blinded, inde-
pendent readers first quantified fibrosis by visual assess-
ment then using thresholds of 2 standard deviations (SD),
3 SD,4 SD,6 SD above the mean of normal, remote myo-
cardium, and 2 SD above noise (2 SDN). The quantifica-
tion was repeated ≥ 4 weeks apart for reproducibility.
Results
DE was present in 51% of subjects, with an interobserver
agreement of 93%. For the detection of fibrosis, 6 SD cor-
related best with visual assessment as compared to 2, 3, 4
SD, or 2 SDN. Average visual quantity of fibrosis was 13 ±
20 g compared with 12 ± 17 g at 6 SD, and 55 ± 31 g at 2
SD, 36 ± 27 g at 3 SD, 25 ± 23 g at 4 SD, and 64 ± 69 g at
2 SDN. All thresholds were significantly correlated with
visual assessment, with 6 SD having the most robust cor-
relation (r = 0.913, p < 0.0001) vs. 2 SD, 3 SD, 4 SD, and
2 SDN (r = 0.806, 0.874, 0.905, 0.533, respectively; all p
< 0.001). Compared with visual assessment, 6 SD had the
lowest intraobserver variability (0.6 ± 8 g, κ = 0.66; p <
0.0001 vs. 1.4 ± 9 g, κ = 0.49; p < 0.0001) and interob-
server variability (5.4 ± 18 g, κ = 0.20; p < 0.0001 vs. -18.4
± 18 g, κ = 0.08; p < 0.0001).
Conclusion
CMR DE thresholding techniques utilizing 6 SD above the
mean of visually normal, remote myocardium appears to
be both an accurate and reproducible method for the
quantification of myocardial fibrosis in HCM. This meth-
odology should be considered for serial assessment of
myocardial fibrosis in longitudinal HCM studies.
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